Seres Therapeutics
MCRB
#8835
Rank
โ‚น13.57 B
Marketcap
โ‚น1,501
Share price
-6.93%
Change (1 day)
3.67%
Change (1 year)

Revenue for Seres Therapeutics (MCRB)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚น10.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seres Therapeutics from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 โ‚น10.49 B1678.54%
2022 โ‚น0.58 B-94.53%
2021 โ‚น10.78 B344.07%
2020 โ‚น2.42 B-1.28%
2019 โ‚น2.46 B24.49%
2018 โ‚น1.97 B-3.57%
2017 โ‚น2.04 B38.58%
2016 โ‚น1.47 B
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Xencor
XNCR
โ‚น15.07 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚น10.15 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
โ‚น4.03 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA